… Itolizumab has been shown to inhibit T cell activation and … whether the inhibitory effect of
CD318 on T cell activation is … mAb act synergistically to inhibit CD4 and CD8 T cell proliferation …

… Current limitations in using chimeric antigen receptor T(CART… –mediated autoimmunity, we
studied the effects of inhibiting … 45% of patients with CLL of Rai stages 0 and 1 exceeded this …

… In our opinion, Particular autoimmune models and … ) ligand 9(CXCL9) and B cell activating
factor (BAFF) from B cells … to Tregs with chimeric antigen receptor (CAR)technology, providing …

… activating 5-HT 2B receptors, whereas dermal thickening was found to be attenuated with
5-HT 2B receptor signaling pathway inhibitors (… or its signaling pathway is inhibited in the CNS. …

… and is being widely used to treat certain autoimmune conditions, such as multiple sclerosis
(… function of Ifit2 in autoimmune inflammation in part by modulating myeloid cell function and …

… STING functions as a negative regulator of endosomal TLR … /TLR–dual signaling in
autoimmune B cell responses was … IFNα signaling positively correlated with B cell activation and …

… as a negative regulator of antigen receptor signaling has … systemic lupus-like autoimmune
disease characterized by … In addition to the widely used Rai-Binet clinical staging systems [65], …

… autoimmune process is the regulation and control of local inflammatory cytokines production.
The deteriorating effects of autoimmune … of insulin signaling through the inhibition of IRS-1 …

… degrades a negative regulator of Fas-induced apoptosis that is cell type-specific. … autoimmune
disorders; however, reducing the value for T cell activation may enhance tumor inhibition …

… Thus, human LIP response is characterized by cytokine and TCR-driven proliferation which
drives global T cell activation but also preferentially triggers regulatory cell expansion which …